法官在夏威夷诉讼案中审查林业发展局关于堕胎药丸使用限制规则的合法性。 Judge reviews legality of FDA's restrictive rules on abortion pill access in Hawaii lawsuit.

夏威夷的一名美国法官正在审查林业发展局对获得堕胎药物mifepristone(堕胎药物)的限制的合法性。 A US judge in Hawaii is examining the legality of FDA restrictions on access to mifepristone, an abortion medication. 美国公民自由联盟(ACLU)和保健协会认为,这些限制,包括对处方和药房的特别认证,以及病人审查咨询表格的要求,过于严格,在科学上没有正当理由。 The American Civil Liberties Union (ACLU) and healthcare associations argue that these restrictions, which include special certifications for prescribers and pharmacies, and a requirement for patients to review a counseling form, are overly stringent and not scientifically justified. 这起案件可以追溯到2017年,旨在确定FDA是否违反了法律而没有立即取消限制. The case, which dates back to 2017, aims to determine if the FDA violated the law without seeking immediate removal of the restrictions.